Publications
2020 Methods for editing genes and genomes
2018 Genes and genome editing: 2nd edition in three volumes
Volume 1 Editing genes and genomes of microorganisms
Volume 2 Editing genes and genomes of plants and animals
Volume 3 Editing genes and genomes. Protocols and guidelines
2016 Editing genes and genomes
2014 Induced pluripotent stem cells 2nd edition
2012 Epigenetics
2011 Induced pluripotent stem cells 2nd edition
Dementyeva E.V., Pavlova S.V., Chernyavsky A.M., Zakian S.M. Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.N515del mutation in MYBPC3. Stem Cell Res. 2021. 53; 102344. doi: 10.1016/j.scr.2021.102344
Dementyeva E.V., Vyatkin Yu.V., Chernyavsky A.M., Zakian S.M. Generation of an induced pluripotent stem cell line, ICGi028-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.E510Q mutation in HADHA. Stem Cell Res. 2021. 53; 102348. doi: 10.1016/j.scr.2021.102348
Malankhanova T., Suldina L., Grigor’eva E., Medvedev S., Minina J., Morozova K., Kiseleva E., Zakian S., Malakhova A. A human induced pluripotent stem cell-derived isogenic model of Huntington’s disease based on neuronal cells has several relevant phenotypic abnormalities. J Pers Med. 2020.10(4):E215. doi: 10.3390/jpm10040215.
Valetdinova K. R., Maretina M. A., Vyatkin Y. V., Perepelkina M. P., Egorova A. A., Baranov V. S., Kiselev A. V., Gershovich P. M., Zakian S. M. Generation of three Duchenne muscular dystrophy patient-derived induced pluripotent stem cell (iPSC) lines ICGi002-A, ICGi002-B and ICGi002-C. Stem Cell Res. 2020. 3;48:101941. doi: 10.1016/j.scr.2020.101941.
Ovechkina V. S., Maretina M. A., Egorova A. A., Baranov V. S., Kiselev A. V., Zakian S. M., Valetdinova K. R. Generation of a spinal muscular atrophy type III patient-specific induced pluripotent stem cell line ICGi003-A. Stem Cell Res. 2020. 3;48:101938. doi: 10.1016/j.scr.2020.101938.
Antonets D. V., Russkikh N., Sanchez A., Kovalenko V. R., Bairamova E. M., Shtokalo D. N., Medvedev S. P., Zakian S. M. CellCountCV-A Web-application for accurate cell counting and automated batch processing of microscopic images using fully convolutional neural networks. Sensors (Basel). 2020. V. 20(13). P. E3653. doi: 10.3390/s20133653.
Malakhova A. A., Grigor’eva E.V., Pavlova S.V., Malankhanova T. B., Valetdinova K. R., Vyatkin Y. V., Khabarova E. A., Rzaev J. A., Zakian S. M., Medvedev S. P. Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population. Stem Cell Res. 2020. 8;48:101952 doi: 10.1016/j.scr.2020.101952.
Malakhova A. A., Grigor’eva E. V., Vasilyeva O. Y., Zhigalina D. I., Skryabin N. A., Sivtcev A. A., Kolesnikov N. A., Bueverov A. O., Lebedev I. N., Bogomolov P. O., Zakian S. M. Generation of two induced pluripotent stem cell lines from peripheral blood mononuclear cells of a patient with Wilson’s disease. Stem Cell Res. 2020. 25;47:101922. doi: 10.1016/j.scr.2020.101922.
Malakhova A. A., Grigor’eva E. V., Vasilyeva O. Y., Zhigalina D. I., Skryabin N. A., Sivtcev A. A., Kolesnikov N. A., Bueverov A. O., Lebedev I. N., Bogomolov P. O., Zakian S. M. Generation of two induced pluripotent stem cell lines from peripheral blood mononuclear cells of a patient with Wilson’s disease. Stem Cell Res. 2020. 25;47:101922. doi: 10.1016/j.scr.2020.101922.
Malakhova A. A., Grigor’eva E. V., Vasilyeva O. Y., Zhigalina D. I., Skryabin N. A., Sivtcev A. A., Kolesnikov N. A., Bueverov A. O., Lebedev I. N., Bogomolov P. O., Zakian S. M. Generation of two induced pluripotent stem cell lines from peripheral blood mononuclear cells of a patient with Wilson’s disease. Stem Cell Res. 2020. 25;47:101922. doi: 10.1016/j.scr.2020.101922.
Dementyeva E. V., Kovalenko V. R., Zhiven M. K., Ustyantseva E. I., Kretov E. I., Vyatkin Y. V., Zakian S. M. Generation of two clonal iPSC lines, ICGi019-A and ICGi019-B, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.M659I mutation in MYH7. Stem Cell Res. 2020. 46:101840. doi: 10.1016/j.scr.2020.101840.
Malakhova A. A., Grigor’eva E. V., Malankhanova T. B., Pavlova S. V., Valetdinova K. R., Abramycheva N. Y., Vetchinova A. S., Illarioshkin S. N., Zakian S. M. Generation of induced pluripotent stem cell line ICGi018-A from peripheral blood mononuclear cells of a patient with Huntington’s disease. Stem Cell Res. 2020. 44:101743. doi: 10.1016/j.scr.2020.101743.
Ustyantseva E. I., Medvedev S. P., Zakian S. M. Studying ALS: Current Approaches, Effect on Potential Treatment Strategy. Adv Exp Med Biol. 2020. 1241:195-217. doi: 10.1007/978-3-030-41283-8_11.
Ustyantseva E. I., Medvedev S. P., Vetchinova A. S., Illarioshkin S. N., Leonov S. V., Zakian S.M. Generation of an induced pluripotent stem cell line, ICGi014-A, by reprogramming peripheral blood mononuclear cells from a patient with homozygous D90A mutation in SOD1 causing Amyotrophic lateral sclerosis. Stem Cell Res. 2020. 42:101675. doi: 10.1016/j.scr.2019.101675.
Grigor’eva E. V., Malankhanova T. B., Surumbayeva A., Minina J. M., Morozov V. V., Abramycheva N. Yu., Illarioshkin S. N., Malakhova A. A., Zakian S. M. Generation of induced pluripotent stem cell line, ICGi007-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington’s disease. Stem Cell Res. 2019. 34:101382. doi: 10.1016/j.scr.2018.101382.
Valetdinova K.R., Maretina M.A., Kuranova M.L., Grigor’eva E.V., Minina Y.M., Kizilova E.A., Kiselev A.V., Medvedev S.P., Baranov V.S., Zakian S.M. Generation of two spinal muscular atrophy (SMA) type I patient-derived induced pluripotent stem cell (iPSC) lines and two SMA type II patientderived iPSC lines. Stem Cell Res. 2019. 34:101376. doi: 10.1016/j.scr.2018.101376.
Grigor’eva E. V., Malankhanova T. B., Ustyantseva E. I., Minina J. M., Redina O. E., Morozov V. V., Shevela A. I., Zakian S. M, Medvedev S. P. Generation of two iPSC lines (ICGi008-A and ICGi008-B) from skin fibroblasts of a patient with early-onset Alzheimer’s disease caused by London familial APP mutation (V717I). Stem Cell Res. 2019. 36:101415. doi: 10.1016/j.scr.2019.101415.
Sharipova D. V., Kovalenko V. R., Bairamova E. M., Vartanova V. A., Grigor’eva E. V., Vyatkin Y. V., Khabarova E. A., Rzaev D. A., Zakian S. M., Medvedev S. P. Generation of two iPSC lines, (ICGi015-A and ICGi015-B), by reprogramming peripheral blood mononuclear cells from a patient with Parkinson’s disease. Stem Cell Res. 2019. 41:101652. doi: 10.1016/j.scr.2019.101652.
Ustyantseva E. I., Medvedev S. P., Vetchinova A. S., Minina J. M., Illarioshkin S. N., Zakian S. M. A Platform for studying neurodegeneration mechanisms using genetically encoded biosensors. BIOCHEMISTRY-MOSCOW. 2019. V. 84. №. 3. P. 299-309. doi: 10.1134/S000629791903012X.
Dementyeva E. V., Medvedev S. P., Kovalenko V. R., Vyatkin Yu. V., Kretov E. I., Slotvitsky M. M., Shtokalo D. N., Pokushalov E. A., Zakian S. M. Applying patient-specific induced pluripotent stem cells to create a model of hypertrophic cardiomyopathy. BIOCHEMISTRY-MOSCOW. 2019. V. 84. № 3. P. 291-298 doi: 10.1134/S0006297919030118.
Valetdinova, K. R., Ovechkina, V. S., Zakian S. M. Methods for Correction of the Single-Nucleotide Substitution c.840C > T in Exon 7 of the SMN2 Gene. BIOCHEMISTRY-MOSCOW. 2019. V. 84(9). P. 1074-1084. doi: 10.1134/S0006297919090104.
Morozova K. N., Suldina L. A., Malankhanova T. B., Grigor’eva E. V., Zakian S. M., Kiseleva E. V., Malakhova A. A. Introducing an expanded cag tract into the huntingtin gene causes a wide spectrum of ultrastructural defects in cultured human cells . PLoS ONE . 2018. V. 13. № 10. С. e0204735. doi: 10.1371/journal.pone.0204735.
Zakharova I. S., Zhiven’ M. K., Saaya Sh. B., Shevchenko A. I., Smirnova A. M., Strunov A., Karpenko A. A., Pokushalov E. A., Ivanova L. N., Makarevich P. I., Parfyonova Y. V., Aboian E., Zakian S. M. Endothelial and smooth muscle cells derived from cardiac explants demonstrate revascularization potential and suitable for design of cell-containing vascular grafts. Journal of Translational Medicine. 2017. V. 15. № 1. P. 54. doi: 10.1186/s12967-017-1156-1.
Malankhanova T. B., Malakhova A. A., Medvedev S. P., Zakian S. M. Modern genome editing technologies in Huntington’s disease research. Journal of Huntington’s Disease. 2017. Vol. 6. № 1. P. 19-31. doi: 10.3233/JHD-160222.